BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou J, Krishnan N, Jiang Y, Fang RH, Zhang L. Nanotechnology for virus treatment. Nano Today 2021;36:101031. [PMID: 33519948 DOI: 10.1016/j.nantod.2020.101031] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Bhatti A, Delong RK. Nanoscale Interaction Mechanisms of Antiviral Activity. ACS Pharmacol Transl Sci 2023. [DOI: 10.1021/acsptsci.2c00195] [Reference Citation Analysis]
2 Idriss H, M. Habib MH, Alakhras AI, El Khair HM. Nano-sized Metal Oxides and Their use as a Surface Disinfectant Against COVID-19: (Review and Perspective). Orient J Chem 2022;38:1328-1337. [DOI: 10.13005/ojc/380601] [Reference Citation Analysis]
3 Chen H, Li Y, Li L, Yang Z, Wen Z, Liu L, Liu H, Chen Y. Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections. Acta Biomater 2022:S1742-7061(22)00852-2. [PMID: 36572250 DOI: 10.1016/j.actbio.2022.12.042] [Reference Citation Analysis]
4 Iqbal R, Khan S, Ali HM, Khan M, Wahab S, Khan T. Application of nanomaterials against SARS-CoV-2: An emphasis on their usefulness against emerging variants of concern. Front Nanotechnol 2022;4. [DOI: 10.3389/fnano.2022.1060756] [Reference Citation Analysis]
5 Hangad MV, Keshvani S, Kelpin N, Walters-shumka J, Hood M, Volk C, Pal D, Willerth SM. Using nanomaterials to address SARS-CoV-2 variants through development of vaccines and therapeutics. Front Mater 2022;9. [DOI: 10.3389/fmats.2022.1039247] [Reference Citation Analysis]
6 Aljabali AAA, Rezigue M, Alsharedeh RH, Obeid MA, Mishra V, Serrano-Aroca Á, Tambuwala MM. Protein-Based Drug Delivery Nanomedicine Platforms: Recent Developments. Pharm Nanotechnol 2022;10:257-67. [PMID: 35980061 DOI: 10.2174/2211738510666220817120307] [Reference Citation Analysis]
7 Taha TB, Barzinjy AA, Hussain FHS, Nurtayeva T. Nanotechnology and Computer Science: Trends and advances. Memories - Materials, Devices, Circuits and Systems 2022;2:100011. [DOI: 10.1016/j.memori.2022.100011] [Reference Citation Analysis]
8 Omran BA, Baek K. Control of phytopathogens using sustainable biogenic nanomaterials: Recent perspectives, ecological safety, and challenging gaps. Journal of Cleaner Production 2022;372:133729. [DOI: 10.1016/j.jclepro.2022.133729] [Reference Citation Analysis]
9 Mougenot MF, Pereira VS, Costa ALR, Lancellotti M, Porcionatto MA, da Silveira JC, de la Torre LG. Biomimetic Nanovesicles—Sources, Design, Production Methods, and Applications. Pharmaceutics 2022;14:2008. [DOI: 10.3390/pharmaceutics14102008] [Reference Citation Analysis]
10 Méndez-garcía LA, Escobedo G, Minguer-uribe AG, Viurcos-sanabria R, Aguayo-guerrero JA, Carrillo-ruiz JD, Solleiro-villavicencio H. Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations. Front Cell Neurosci 2022;16:977039. [DOI: 10.3389/fncel.2022.977039] [Reference Citation Analysis]
11 Alkhalefa N, Khaliel S, Tahoon A, Shaban H, Magouz A, Ghabban H, Lokman MS, Elmahallawy EK. In vitro investigation of the antiviral activity of propolis and chitosan nanoparticles against the genotype VII Newcastle disease virus. Front Vet Sci 2022;9. [DOI: 10.3389/fvets.2022.947641] [Reference Citation Analysis]
12 Krishnan N, Kubiatowicz LJ, Holay M, Zhou J, Fang RH, Zhang L. Bacterial membrane vesicles for vaccine applications. Adv Drug Deliv Rev 2022;185:114294. [PMID: 35436569 DOI: 10.1016/j.addr.2022.114294] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
13 Zoulikha M, Huang F, Wu Z, He W. COVID-19 inflammation and implications in drug delivery. J Control Release 2022;346:260-74. [PMID: 35469984 DOI: 10.1016/j.jconrel.2022.04.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chen HH, Lin CJ, Anand A, Lin HJ, Lin HY, Mao JY, Wang PH, Tseng YJ, Tzou WS, Huang CC, Wang RYL. Development of antiviral carbon quantum dots that target the Japanese encephalitis virus envelope protein. J Biol Chem 2022;298:101957. [PMID: 35452675 DOI: 10.1016/j.jbc.2022.101957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Zeng H, Li J, Hou K, Wu Y, Chen H, Ning Z. Melanoma and Nanotechnology-Based Treatment. Front Oncol 2022;12:858185. [PMID: 35356202 DOI: 10.3389/fonc.2022.858185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Wang Q, Jiang J, Gao L. Catalytic antimicrobial therapy using nanozymes. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2022;14:e1769. [PMID: 34939348 DOI: 10.1002/wnan.1769] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Kontogiannis O, Karalis V. On the in vivo kinetics of gene delivery vectors.. [DOI: 10.1101/2022.02.11.22269834] [Reference Citation Analysis]
18 Zhou J, Ventura CJ, Fang RH, Zhang L. Nanodelivery of STING agonists against cancer and infectious diseases. Mol Aspects Med 2022;83:101007. [PMID: 34353637 DOI: 10.1016/j.mam.2021.101007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 Abolmaali SS, Alimardani V, Farahavar G, Najafi H, Shafiee M, Tanideh N, Tamaddon AM, Ahadian S. Nanotechnology-based approaches against COVID-19. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance 2022. [DOI: 10.1016/b978-0-323-90792-7.00012-9] [Reference Citation Analysis]
20 Sadeghian I, Heidari R, Sadeghian S, Raee MJ, Negahdaripour M. Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines. Eur J Pharm Sci 2021;169:106094. [PMID: 34896590 DOI: 10.1016/j.ejps.2021.106094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
21 Krishnan N, Fang RH, Zhang L. Engineering of stimuli-responsive self-assembled biomimetic nanoparticles. Adv Drug Deliv Rev 2021;179:114006. [PMID: 34655662 DOI: 10.1016/j.addr.2021.114006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
22 Garip Ustaoğlu Ş, Kaygusuz H, Bilgin MD, Severcan F. Novel approaches for COVID-19 diagnosis and treatment: a nonsystematic review. Turk J Biol 2021;45:358-71. [PMID: 34803440 DOI: 10.3906/biy-2105-45] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Bello-Lopez JM, Silva-Bermudez P, Prado G, Martínez A, Ibáñez-Cervantes G, Cureño-Díaz MA, Rocha-Zavaleta L, Manzo-Merino J, Almaguer-Flores A, Ramos-Vilchis C, Rodil SE. Biocide effect against SARS-CoV-2 and ESKAPE pathogens of a noncytotoxic silver-copper nanofilm. Biomed Mater 2021;17. [PMID: 34673548 DOI: 10.1088/1748-605X/ac3208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
24 Duan Y, Wang S, Zhang Q, Gao W, Zhang L. Nanoparticle approaches against SARS-CoV-2 infection. Curr Opin Solid State Mater Sci 2021;25:100964. [PMID: 34729031 DOI: 10.1016/j.cossms.2021.100964] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
25 Ai X, Wang D, Honko A, Duan Y, Gavrish I, Fang RH, Griffiths A, Gao W, Zhang L. Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition. J Am Chem Soc 2021;143:17615-21. [PMID: 34647745 DOI: 10.1021/jacs.1c07798] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
26 Liu H, Zhong W, Zhang X, Lin D, Wu J. Nanomedicine as a promising strategy for the theranostics of infectious diseases. J Mater Chem B 2021;9:7878-908. [PMID: 34611689 DOI: 10.1039/d1tb01316e] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 Pereira-Silva M, Chauhan G, Shin MD, Hoskins C, Madou MJ, Martinez-Chapa SO, Steinmetz NF, Veiga F, Paiva-Santos AC. Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination. Expert Opin Drug Deliv 2021;:1-20. [PMID: 33944644 DOI: 10.1080/17425247.2021.1922387] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
28 de Castro KC, Costa JM. Polymeric surfaces with biocidal action: challenges imposed by the SARS-CoV-2, technologies employed, and future perspectives. J Polym Res 2021;28. [DOI: 10.1007/s10965-021-02548-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Pippa N, Gazouli M, Pispas S. Recent Advances and Future Perspectives in Polymer-Based Nanovaccines. Vaccines (Basel) 2021;9:558. [PMID: 34073648 DOI: 10.3390/vaccines9060558] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
30 Meng QF, Tian R, Long H, Wu X, Lai J, Zharkova O, Wang JW, Chen X, Rao L. Capturing Cytokines with Advanced Materials: A Potential Strategy to Tackle COVID-19 Cytokine Storm. Adv Mater 2021;33:e2100012. [PMID: 33837596 DOI: 10.1002/adma.202100012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
31 Pisani A, Bardi G. Immunology of biodegradable nanoparticles: a brief overview on a wide growing field. Explor Immunol. [DOI: 10.37349/ei.2021.00006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
32 Yang KC, Lin JC, Tsai HH, Hsu CY, Shih V, Hu CJ. Nanotechnology advances in pathogen- and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control. Drug Deliv Transl Res 2021;11:1420-37. [PMID: 33748879 DOI: 10.1007/s13346-021-00965-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
33 Jat SK, Gandhi HA, Bhattacharya J, Sharma MK. Magnetic nanoparticles: an emerging nano-based tool to fight against viral infections. Mater Adv 2021;2:4479-96. [DOI: 10.1039/d1ma00240f] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]